MEK1/2 and its downstream kinases ERK1/2 have been implicated in radioresistance in HNSCC before, although the effect of pathway inhibition on radiosensitivity is inconsistent[8,25]. The gene discussed is MAPK3; the disease is head and neck squamous cell carcinoma.